Osteochondrosis is most often diagnosed in the elderly, as a result of the general aging of the body, but enough cases when they suffer and young people. This disease of the spine, which is caused by different factors, and leads to the same result - the deformation of intervertebral discs.
Causes of osteochondrosis
Osteochondrosis develops gradually and is susceptible to it more often by people who have an impaired distribution of the axial load on the vertebral column due to flatfoot or overweight, persons leading a sedentary lifestyle engaged in lifting weights and constantly being forced to be in the same position. There are data that confirm the dependence of the onset of this disease on autoimmune disorders in the body and on weights of hereditary factors.
Osteochondrosis occurs in all cases when the cartilaginous tissue of the intervertebral disc changes - the reason is the decrease in the content of chondroitin sulfate, which is responsible for the elasticity and moisture content. As a result, cartilaginous tissue decreases in size, a dystrophic change in the intervertebral disc occurs, which necessarily entails disruption of the ligamentous apparatus and deformation of the spinal processes of the spinal column.
Application of chondroprotectors
Now the best of all means are chondroprotectors in osteochondrosis. This by no means means that these medicines can heal the patient - the nature of the disease is such that cartilage can not be restored, but it is possible to prevent further regression of the intervertebral discs. Chondroprotectors contain in their composition glucosamine and, the same, chondroitin sulfate, which act as a food for the cartilage, thus contributing to its elasticity and the state of retaining moisture.
These substances are completely natural substitutes for those that disappear in this disease, and play the role of crutches for intervertebral discs. When taking chondroprotektora normalization of bone metabolism, increased synthesis of glucosamines, an increase in the number of lipids and fibrins in the blood vessels that feed the spinal column. It can be said that normalization of all functions of cartilaginous tissue takes place, therefore, the appointment of chondroprotectors in the treatment of osteochondrosis is justified and shown at the first signs of the disease.
The experience of treating osteochondrosis with mono-preparations of glucosamine and chondroitin has already been accumulated, and it is concluded that the best results are achieved with the use of complex preparations, where these substances are contained in therapeutic doses. Manufacturers sometimes combine chondroprotectors with nonspecific anti-inflammatory substances, but this is justified only if there is an inflammatory process in the tissues surrounding the intervertebral disc, in all others - where the disease is caused by degenerative changes in the cartilaginous tissue, NIP may not be used.
In clinical practice, many traumatologists and orthopedists recognize the advisability of using such drugs in the therapy of musculoskeletal diseases, their almost hundred percent effectiveness is proved experimentally, and the previously existing question of harmlessness for the rest of the body systems is practically solved positively. Reception of chondroprotectors should be continued for a sufficiently long time, and negative reactions in experimental groups of patients are not revealed, with the exception of a certain decrease in blood clotting, so such patients should undergo medical treatment under the supervision of a doctor and regularly monitor blood composition.
We advise reading about the use of papillary patch and applicator Kuznetsova with osteochondrosis.